Frequency of acquired von Willebrand's disease in children with congenital heart disease

Acta Cardiologica

Volumn 62, Issue 4, 2007, Pages 403-408

  Arslan, Mehmet Tayip ^a,b   Ozyurek, Ruhi ^a   Kavakli, Kaan ^a   Levent, Erturk ^a   Ulger, Zulal ^a   Gurses, Dolunay ^a   Akyol, Bedir ^a   Atay, Yüksel ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Acquired von Willebrand's disease; Bleeding; Congenital heart disease

Indexed keywords

RISTOCETIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; BLEEDING TENDENCY; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; FEMALE; HEART SURGERY; HUMAN; MALE; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADOLESCENT; AGE FACTORS; AGGLUTINATION; ANTIGENS; BIOLOGICAL MARKERS; BLOOD GROUPING AND CROSSMATCHING; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; LINEAR MODELS; MALE; PLATELET COUNT; POSTOPERATIVE PERIOD; TURKEY; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 34548185957     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.62.4.2022285     Document Type: Article

References (21)

1. Bahnson HT, Ziegler RF. A consideration of the causes of death following operation for congenital heart disease of the cyanotic type. Surg Gynecol Obstet 1950; 90: 60-76.
2. Hartmann RC. A hemorrhagic disorder occurring in patients with cyanotic congenital heart disease. Bull Johns Hopkins Hosp 1952; 91: 49-67.
3. Colon-Otero G, Gilchrist GS, Holcomb GR, Ilstrup DM, Bowie EJ. Preoperative evaluation of hemostasis in patients with congenital heart disease. Mayo Clin Proc 1987; 62: 379-85.
4. Maurer HM, McCue CM, Robertson LW, Haggins JC. Correction of platelet dysfunction and bleeding in cyanotic congenital heart disease by simple red cell volume reduction. Am J Cardiol 1975; 35: 831-5.
5. Henriksson P, Varendh G, Lundstrom NR. Haemostatic defects in cyanotic congenital heart disease. Br Heart J 1979; 41: 23-7.
6. Gross S, Keefer V, Liebman J. The platelets in cyanotic congenital heart disease. Pediatrics 1968; 42: 651-8.
7. Waldman JD, Czapek EE, Paul MH, Schwartz AD, Levin DL, Schindler S. Shortened platelet survival in cyanotic heart disease. J Pediatr 1975; 87: 77-9.
8. Goldschmidt B. Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease. Acta Paediatr Acad Sci Hung 1970; 11: 135-9.
9. Tran TC, Mannucci PM, Schneider P, Federici AB, Bachmann F. Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma. Br J Haematol 1985; 61: 307-14.
10. Duran-Saurez JR, Pico M, Zuazu J, Cortes M, Monasterio J, Tringiner J. Acquired von Willebrand's disease caused by a chronic granulocytic leukemia. Br J Haematol 1981; 48: 173-5.
11. Mannucci PM, Mari D. Antibodies to factor VIII/von Willebrand factor in congenital and acquired von Willebrand's disease. Prog Clin Biol Res 1984; 150: 109-22.
12. Kreuz W, Linde R, Funk M, Meyer-Schrod R, Foll E, Nowak-Gottl U, Jacobi G, Vigh Z, Scharrer I. Induction of von Willebrand disease type 1 by valproic acid. Lancet 1990; 335: 1350-1.
13. Conrad ME, Latour LF. Acquired von Willebrand's disease, IgE polyclonal gammopathy and griseofulvin therapy. Am J Hemat 1992; 41: 143.
14. Castaman G, Lattuada A, Mannucci PM, Rodeghiero F. Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor. Am J Hematol 1995; 49: 83-6.
15. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci U S A 1990; 87: 6306-10.
16. Pareti FI, Lattuada A, Bressi C, Zanobini M, Sala A, Steffan A, Ruggeri ZM. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000; 102: 1290-5.
17. Gill JC, Wilson AD, Endres-Brooks J, Montgomery RR. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 1986; 67: 758-61.
18. Froom P, Margulis T, Grenadier E, Palant A, David M, Aghai E. Von Willebrand factor and mitral valve prolapse. Thromb Haemost 1988; 60: 230-1.
19. Rauch R, Budde U, Koch A, Girisch M, Hofbeck M. Acquired von Willebrand syndrome in children with patent ductus arteriosus. Heart 2002; 88: 87-8.
20. McCallum CJ, Peake IR, Newcombe RG, Bloom AL. Factor VIII levels and blood group antigens. Thromb Haemost 1983; 50: 757.
21. Vincentelli A, Susen S, Le Tourneau TL, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349: 343-9.